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Abstract
Background: Computational/manual annotations of protein functions are one of the first routes to making sense
of a newly sequenced genome. Protein domain predictions form an essential part of this annotation process. This
is due to the natural modularity of proteins with domains as structural, evolutionary and functional units.
Sometimes two, three, or more adjacent domains (called supra-domains) are the operational unit responsible for a
function, e.g. via a binding site at the interface. These supra-domains have contributed to functional diversification
in higher organisms. Traditionally functional ontologies have been applied to individual proteins, rather than
families of related domains and supra-domains. We expect, however, to some extent functional signals can be
carried by protein domains and supra-domains, and consequently used in function prediction and functional
genomics.
Results: Here we present a domain-centric Gene Ontology (dcGO) perspective. We generalize a framework for
automatically inferring ontological terms associated with domains and supra-domains from full-length sequence
annotations. This general framework has been applied specifically to primary protein-level annotations from
UniProtKB-GOA, generating GO term associations with SCOP domains and supra-domains. The resulting ‘dcGO
Predictor’, can be used to provide functional annotation to protein sequences. The functional annotation of
sequences in the Critical Assessment of Function Annotation (CAFA) has been used as a valuable opportunity to
validate our method and to be assessed by the community. The functional annotation of all completely sequenced
genomes has demonstrated the potential for domain-centric GO enrichment analysis to yield functional insights
into newly sequenced or yet-to-be-annotated genomes. This generalized framework we have presented has also
been applied to other domain classifications such as InterPro and Pfam, and other ontologies such as mammalian
phenotype and disease ontology. The dcGO and its predictor are available at http://supfam.org/SUPERFAMILY/
dcGO including an enrichment analysis tool.
Conclusions: As functional units, domains offer a unique perspective on function prediction regardless of whether
proteins are multi-domain or single-domain. The ‘dcGO Predictor’ holds great promise for contributing to a
domain-centric functional understanding of genomes in the next generation sequencing era.
Background
The first decade of this century has seen the rapid accu-
mulation of vast genome-scale sequences, largely fuelled
by the next generation sequencing technologies. Although
these massive amounts of data offer an unprecedented
opportunity for addressing many fundamental questions
in the field of biomedical science [1,2], yet making sense
of these raw sequences on their own represents a tremen-
dous challenge. A large body of new protein sequences is
awaiting functional annotations [3,4], which trails far
behind by the rate of genome sequencing. Classically,
sequence-function relationships for a protein are largely
evident through looking at its structural properties. One of
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the most obvious structural properties for the protein is
modular design, with domains forming distinct globular
structural units. Apart from structural units, 3D domains
are also evolutionarily related. For example, the Structural
Classification of Proteins (SCOP) database [5] defines
domains as the smallest unit of evolution. When it comes
to function, however, we are accustomed to considering
whole proteins despite the fact that very often domains
can be functional units. As a matter of fact, domains can
carry out many aspects of protein functions, and are
widely used as functional predictors. Among current
methods for computational protein function annotation/
prediction [6,7], the structure-based methods are increas-
ingly popular [8,9] as more structures are and will be
resolved experimentally and deposited digitally in the Pro-
tein Data Bank (PDB) [10]. Without referring to detailed
residual information of primary sequences, structural
information at the domain level is closely relevant to bio-
logical functions. In principle, the coverage of functional
annotations can be dramatically improved by in silico
transferring known functions of proteins to those un-
annotated proteins via their shared structures [11,12].
Hence, generating domain-centric functional annotations
is necessary to realize such automated protein function
transfer/prediction.
SCOP domains defined at superfamily and/or family
levels are decent choices regarding the above-mentioned
three aspects (structural, evolutionary and functional) of
protein modularity [5]. At the superfamily (or evolution-
ary) level, domains are distantly related with evidence
for common ancestry; within the same superfamily,
domains are further divided into the family level
wherein domains are often related by sequence similar-
ity [13]. Based on SCOP, the SUPERFAMILY database
uses hidden Markov models to detect and classify SCOP
domains at both the superfamily and family levels [14].
Consequently, each protein sequence may be repre-
sented as a string of SCOP domains, called domain
architectures [15]. To better understand the functional
aspect of SCOP domains, recently we have also pro-
posed a framework for automatically inferring the
domain-centric annotations from the existing protein-
level Gene Ontology (GO) annotations, and thereafter
deriving a list of GO terms that are of most relevance to
individual SCOP domains [16]. Although they are useful
in describing functionally independent domains, most
domains may not just function alone. When surveying
domain compositions of proteins in the latest version of
the UniProt Knowledgebase (UniProtKB) [17], we find
that up to 70% are predicted to be multi-domain pro-
teins. In multi-domain proteins, two or more domains
can combine together, thus conferring functional plasti-
city. The recombination of the existing domains in
multi-domain proteins is considered as one of driving
forces for gaining functions (neo-functions or more
complex functions) [18]. The combinations of two or
more successive domains can be viewed as ‘supra-
domains’ if they exist in different domain architectures
[19]. In other words, supra-domain combinations can be
found in different full-length domain architectures and
act as larger evolutionary units greater in size than a
single domain yet not necessarily a complete full-length
protein architecture. Given the combinatorial nature of
supra-domains, their functions are not practical to char-
acterize in a labor-intensive manner. Supra-domains are
far more difficult than individual domains to manually
curate by looking at the functions of multi-domain pro-
teins they reside in. Motivated by these challenges, addi-
tional research is warranted to explore how domain
combinations contribute to function diversifications. It
also remains to show whether the previously proposed
framework can be extended to infer GO terms suitable
for supra-domains in addition to individual domains.
More importantly, there is a need to clarify the utility of
GO-annotated domains and supra-domains in function
prediction and other aspects of functional mining.
In an attempt to address the questions mentioned
above, we first generalized our previous framework for
capturing GO terms suitable for annotating both indivi-
dual domains and supra-domains. Using the concept of
reverse engineering, at the core of this domain-centric
approach is: if a GO term tends to annotate a set of pro-
teins containing a certain domain (or a set of proteins
containing a supra-domain), then this term should also
carry out functional signals for that domain (or supra-
domain). Biologically, the resulting domain-centric GO
(dcGO) annotations have carried on hidden functional
signals buried under existing annotated proteins. Metho-
dologically, this resource has taken into account the
structural organization of GO by performing two types of
statistical inference. Because of these considerations, a
domain (supra-domain) can be associated with multiple
GO terms (if any) that are informative to annotate it, and
thus allowing multiple associations between domains and
GO terms (quite similar to those between proteins and
GO terms). Since the inferred dcGO can preserve the
input information at the protein level, to some extent our
approach addresses the challenges like one-domain-
many-functions and one-function-many-domains (if
there exists any evidence to support one2many associa-
tions). With the dcGO annotations at hand, we then
developed ‘dcGO Predictor’ to predict functions of the
target sequences in the CAFA experiment, an interna-
tional competition for automatic protein function and
critical assessment [20]. Finally, we derived meta-GO
terms (GO slims) of different specificities, and showcased
their related dcGO annotations to facilitate our un-
derstanding of functional implications in sequenced
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genomes. These results demonstrated the ability of the
domain-centric solution towards function predictions
and functional genomics.
Results and discussion
A domain-centric GO approach to automatically infer GO
annotations for individual domains and supra-domains
The structural domain information of a protein is closely
relevant to biological functions it has. To reveal the extent
of functional signals carried by protein domains (and
supra-domains in the multi-domain proteins), we devel-
oped a domain-centric Gene Ontology (dcGO) approach
(Figure 1; see also Methods for details), a generalized
extension to our previous proposal [16]. Briefly, the imple-
mentation of this approach started from high-coverage
domain architectures and high-quality GO annotations for
proteins (obtained respectively from SUPERFAMILY [21]
and UniProKB-GOAs [22]), resulting in the correspon-
dence matrix between domains/supra-domains and GO
terms. Based on this matrix, two types of statistical infer-
ence (i.e., overall and relative inference) were performed
while respecting the directed acyclic graph (DAG) of GO;
these dual inferences aimed to ensure that only the most
relevant GO terms could be retained. A false discovery
rate (FDR) [23] was then calculated to measure signifi-
cance of inference, while a hypergeometric score (h-score)
used to indicate the strength of inference. Finally, we pro-
pagated the inferred GO terms to all their ancestors, gen-
erating the complete GO annotations for a domain/supra-
domain. The middle panel in Figure 1 gives an account of
analytic details, while the right panel illustrates an example
of how to infer possible associations between a supra-
domain ‘82199,57667’ (’82199’ stands for ‘SET domain’,
and ‘57667’ for ‘beta-beta-alpha zinc fingers’) and a GO
term ‘GO:0019827’ (’stem cell maintenance’). The full
results for this example are accessible at [24]. From this
link and the Figure 1, we can see a significant association
between the supra-domain and the GO term (FDR =
4.96E-8). Interestingly, among the two domains constitut-
ing this supra-domain, only ‘SET domain’ is associated
with ‘stem cell maintenance’ (FDR = 7.15E-3; inherited
annotation), but not for ‘beta-beta-alpha zinc fingers’. This
example clearly shows the necessity of associating two or
longer supra-domains with GO terms, as functional units
can consist of more than one domain acting together or
acting at an interface between domains.
The resulting dcGO resource is available at [25],
wherein the ‘BROWSE’ navigation on the left provides
two options for accessing the resource. The first one is a
SCOP-orientated option to obtain a list of GO terms
annotated to individual domains (if annotatable), such as
‘Triosephosphate isomerase (TIM)’ [26]. The second
option is a GO-orientated view to list those domains/
supra-domains annotated by a GO term, like ‘serine-type
peptidase activity’ [27] and ‘stem cell maintenance’ [24].
Such displays, if combined with a species tree of life
(such as provided by SUPERFAMILY [28,29]), can greatly
facilitate evolutionary analyses of either an individual
domain of interest or sets of domains annotated by a GO
term of interest.
Table 1 summarizes statistics in terms of annotatable
domains/supra-domains, GO terms used, the total annota-
tions observed, and the annotation density (defined as the
ratio of the observed against the theoretical). Although
annotatable supra-domains outnumber individual
domains, the percentage of all possible supra-domains to
be annotated is the lowest (27%~37%), compared to indivi-
dual domains (46%~52% at SCOP family level and 64%
~71% at SCOP superfamily level). When it comes to anno-
tation density, however, these triple domain types share
the same range for each of three GO ontologies, including
Biological Process (BP, 0.008~0.013), Molecular Function
(MF, 0.006~0.008) and Cellular Component (CC,
0.013~0.024). This un-skewed annotation density partially
implies that dcGO approach has no biases towards proces-
sing individual domains and supra-domains. Although
many more annotations will be inferred in the future as
primary source databases improve, we do not expect the
annotation density to change dramatically from one fort-
night update to the next.
CAFA function prediction using GO annotations of both
individual domains and supra-domains
To maximize performance, protein function prediction
should integrate different kinds of predictive features
[30-33], including the primary sequence for blast compari-
sons and non-sequence relevant features such as expres-
sion levels, sub-cellular localizations and protein-protein
interactions, to name but a few examples. Rather than to
train a multi-feature classifier or make consensus annota-
tions, here we aim to show the contribution made to func-
tion prediction by the single-method dcGO direct
annotations. Viewing domains as functional units renders
the (organism independent) function prediction of poorly
annotated proteins with known/predicted domains fairly
straightforward. It was achieved via ‘dcGO Predictor’ [34].
The implementation first considers the domain composi-
tion of a target protein, and subsequently transfers any
GO annotations of its residential domains/supra-domains
to the target. The predictive score (p-score) is calculated
to reflect the confidence of such predictions/transfers. We
applied ‘dcGO Predictor’ to target sequences provided in
the CAFA experiment (See the Methods section for
details). Briefly, GO terms for MF and BP were predicted
for these targets (7 eukaryotic sets and 11 prokaryotic
sets), resulting in a list of terms along with a predictive
score for each of targets. Then, these predictions were
evaluated by the precision-recall (PR-RC) analysis against
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gold standard true annotations manually curated in a per-
iod of more than one year. Finally, all individual target PR-
RC values were averaged to produce PR-RC values for
each of the eukaryotic sets or the whole sets for eukaryote
(and prokaryote).
We first examined the PR-RC curves of our prediction
using both domains and supra-domains for eukaryotic sets
(Figure 2A). Considering purely domain information is
used, dcGO predictions were remarkably successful in
recovering true functional annotations. Our prediction
yielded the best results for Euk_set6, which is consistent
with the highest percentages of annotatable domains/
supra-domains. We also found that using GO terms in
MF (top panel in Figure 2A) outperformed using those in
Figure 1 A domain-centric GO approach to automatically infer GO annotations for individual domains and supra-domains. The
flowchart in the left panel illustrates three major steps of the proposed approach, including (Step 1) the preparation of the correspondence
matrix between domains/supra-domains and GO terms from protein-level annotations in UniProtKB-GOA and domain architectures in
SUPERFAMILY database, (Step 2) two types of statistical inference followed by FDR calculation, and (Step 3) following the true-path rule to obtain
the complete domain-centric GO annotations. The overall inference (I), relative inference (II) and the significance measure (III) are illustrated in
the middle panel, both mathematically and graphically. Further illustration (IV) is given by specifying an example of inferring associations
between a supra-domain (i.e., ‘82199,57667’) and a GO term (i.e., ‘stem cell maintenance’) in the right panel. Notably, there are a total of three
direct parental GO terms (i.e., ‘developmental process’, ‘negative regulation of cell differentiation’, and ‘stem cell development’) for ‘stem cell
maintenance’, and Npa is the total number of Uniprots that can be annotated by any direct parental GO terms.
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BP (bottom panel in Figure 2A), indicating that molecular
functional aspect is more relevant to describing the
domains/supra-domains. Interestingly, limiting the predic-
tion to the individual domains only slightly reduced per-
formance when plotting PR-RC curves for the whole
eukaryotic sets (Figure 2B). Further examination of
domain compositions of these eukaryotic targets reveals
that only one-third of the targets were of multi-domain
proteins, which is far less than the average of 70% for
eukaryotic proteins (as discussed in the Background sec-
tion). We expect that the inclusion of supra-domains
would lead to much better function prediction if a more
representative set of multi-domain targets were to be
included. When applied to prokaryotic sets (for which
there is insufficient data for a proper evaluation, as stated
in the CAFA experiment [20]), surprisingly we observed a
similar overall performance to the eukaryotic sets (Figure
3C). This observation partially implies that the dcGO
approach is not so sensitive to the sequences of different
origins as long as these sequences to be predicted are not
so atypical in terms of domain content they have.
’dcGO Predictor’ is not just computationally efficient,
but brings additional understanding to the annotation at
a sub-protein resolution. Using modular domains is not
just conceptually more intuitive, but easier to implement
than other more complex methods. For example, we
have extended the generalized domain-centric approach
to other InterPro signatures [35]. The additional domains
in InterPro further improve the predictive performance
described above (Additional file 1). Notably, the revised
version of ‘dcGO Predictor’ (as described here using
h-scores to calculate p-scores) is more discriminative
than the old version (used in CAFA before 15th, Septem-
ber 2010) that used the FDR to calculate p-scores. As
shown in Additional file 2, the old version misses the
‘higher precision but lower recall’ part of PR-RC curves.
This is because the FDR does not discriminate between
high-scoring predictions (they all collapse to FDR = 0).
Conversely, h-scores differ between the top predictions.
The derivation of meta-GO terms and their application to
functional genomic analyses
The ‘dcGO Predictor’ for function prediction in the CAFA
experiment validates the quality of this dcGO annotations
resource. To extend the usefulness of the resource, we gen-
erated meta-GO terms (Figure 3). Similar to the concept of
GO slims [36], these meta-GO terms contain a subset of
terms appearing in dcGO annotations but allow for a
grain-specific view of the content. They were obtained by
partitioning GO according to specificity measured in the
form of information content (IC). As summarized in the
bottom panel of Figure 3, meta-GO terms were divided
into four levels of increasing specificity: highly general, gen-
eral, specific, and highly specific. In agreement with the
pyramid-like shape of the GO hierarchy, increasing specifi-
city led to an increase in the number of GO terms in all
cases. For a given ontology and a given specificity, we also
noticed that there existed a similar number of GO terms,
suggesting comparable compositions of meta-GO terms
for individual domains and supra-domains.
Since the derived meta-GO terms provide a grain-speci-
fic overview, restricting their related dcGO annotations
(rather than all of them) is particularly useful for GO term
enrichment analysis. This kind of enrichment analysis is
commonly employed for interpreting transcriptome data
(such as by us [37,38] and others [39,40]), and can be gen-
erally applied to any large-scale dataset if provided with
knowledge-specific annotations. To reveal the functional
insights into newly sequenced or yet-to-be-annotated gen-
omes, we viewed their domainome (a complete set of
domains present thereof) as functional carriers and per-
formed enrichment analysis using meta-GO terms and
domain-centric annotations. So far, we have applied such
functional genomic analysis to all sequenced eukaryote
Table 1 A summary of statistics for domain-centric GO annotations.
Ontology1 #Domains2 #Terms3 #Annotations4 #Density5
3,246 FA domains6 BP 1,696 6,699 106,855 9.41E-03
MF 1,544 1,937 19,329 6.46E-03
CC 1,490 902 30,084 2.24E-02
1,660 SF domains7 BP 1,177 8,632 127,680 1.26E-02
MF 1,096 2,253 20,009 8.10E-03
CC 1,054 1,134 28,636 2.40E-02
14,531 supra-domains8 BP 5,363 5,982 256,648 8.00E-03
MF 3,972 1,472 33,355 5.70E-03
CC 4,260 820 61,245 1.75E-02
1BP = Biological Process, MF = Molecular Function, CC = Cellular Component; 2The number of annotatable domains/supra-domains; 3The number of GO terms
used to annotate; 4The total number of domain-centric GO annotations; 5Annotation density is defined as the observed (i.e., #Annotations) divided by the
theoretical (a multiplication of #Domains and #Terms); 6A total of 3,246 distinct domains at SCOP family (FA) level; 7A total of 1,660 distinct domains at SCOP
superfamily (SF) level; 8A total of 14,531 possible supra-domains.
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genomes provided by the SUPERFAMILY database. As
a proof of principle, analysis of a recently sequenced
and rapidly evolving animal lineage, Oikopleura dioica
[41], showed that the enriched GO terms were diverse,
representing a wide spectrum of functions involved in
energy metabolism, organ/tissue development, responses to
stress/stimulus, cell communication and signal transduction
(Additional file 3). These functional implications are not
Figure 2 The performance of dcGO Predictor in the CAFA experiment. To evaluate function prediction, true prediction rate (precision:
TP/[TP+FP]) and true positive rate (recall: TP/[TP+FN]), both as a function of the predictive score (see Methods) are plotted as a precision-recall
(PR-RC) curve. (A) PR-RC curves for each of 7 sets of eukaryotic sequence targets, separately calculated using (top panel) the Molecular Function
(MF) and (bottom panel) Biological Process (BP) ontologies. These predictions are based on GO annotations of both domains and supra-domains.
(B) Comparisons of prediction using both domains and supra-domains against that using domains. PR-RC curves plotted here are for all
eukaryotic sets as a whole. (C) Comparisons of PR-RC curves between eukaryotic sets and prokaryotic sets.
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only consistent with our previously identified over-repre-
sented domains (as compared to other eukaryotes) [42],
but also provide a possible direction for future studies to
clarify these observations in greater detail. In a second
case, we analyzed three unicellular genomes (Capsaspora
owczarzaki, Monosiga brevicollis, and Proterospongia).
These genomes are phylogetically located at the animal-
fungal boundary and thus afford an important look at the
origin of the multicellular animals [43-46]. As listed in
Additional file 4, these genomes shared quite a similar
Figure 3 Flow diagram of generating meta-GO terms through information content analysis of domain-centric GO annotations. Briefly,
all GO terms in DAG are initially unmarked. Then, identify those unmarked GO terms with IC closest to a predefined IC (e.g., 1). Mark those
identified terms and all of their ancestors and descendants, being excluded from further search. Continue the previous two steps to iteratively
identify unmarked GO terms until all GO terms in DAG are marked. Finally, output only those identified GO terms with IC falling in the range (e.
g., [0.75 1.25]) as a meta-GO. The bottom panel displays the compositions in meta-GO terms for domains at SCOP family (FA) level, at SCOP
superfamily (SF) level, and supra-domains.
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profile of GO enrichments, including metabolic processes,
catalytic molecular function, and cellular organelle (parti-
cularly mitochondrion). Catalytic function and related
metabolic processes appeared to a reasonable result of a
large number of catalytic domains observed [45,47], which
is becoming the focus of considerable research [48,49].
The functional involvement of mitochondrion was prob-
ably reflective of the importance of mitochondrial gen-
omes in putting themselves as an out-group to animals
[50]. In the near future, we will extend these functional
genomic analyses in a context of a species tree to reveal
functional trends in the course of eukaryotic evolution.
Other than the genomic data stored in SUPERFAMILY,
user-submitted domains are also supported for enrich-
ment analysis. This ‘dcGO Enrichment’ [51] can provide
the interpretations for a predefined list of domains of
interest, for example, a list of unusual domains found in a
genome as compared to other genomes.
Conclusions
In this work, we present a domain-centric GO approach of
using protein-level annotations and structural information
to detect functional signals inherent in the residential
domains/supra-domains. Under this principle we have
developed ‘dcGO Predictor’ as a functional annotation
tool and we demonstrate its utility for protein function
prediction in the CAFA experiment. Since ‘dcGO Predic-
tor’ was not conceived as a competitor for the many
multi-feature classifiers trained to perform on the CAFA
test, its relative success as a single direct method justifies
its unique value. The generality of the method has allowed
us to include many other biomedical ontologies in addi-
tion to GO, and allows it to be adopted more widely by
other domain databases such as those in the InterPro
consortium.
Using as a functional annotation tool, we demonstrate
its utility for protein function prediction in the CAFA
experiment, and this kind of domain-centric functional
information should be incorporated into any future studies
of genome annotations. We also generate meta-GO terms
of different specificities and showcase their use for
domain-based functional genomics. These results have
already provided us and others (such as [52]) with a
resource to understand the > 80 million (at the time of
writing) sequences, both structurally and functionally.
Methods
Protein-level GO annotations in the UniProtKB-GOA
database
GO annotations for proteins over a wide spectrum of spe-
cies (~2,000) were downloaded from the UniProtKB on
19th, November 2011 [22]. Only those annotations using
experimental or manual evidence codes [53] were
retrieved so as to minimize the false-positives as training
input. In total, there remained more than 157,000 proteins
with at least a high-quality GO annotation. Almost half of
annotations to these proteins were supported by the two
top evidence codes, either ‘IDA’ (i.e., direct assay) or ‘IMP’
(i.e., mutant phenotype).
Protein domain assignments in the SUPERFAMILY
database
In the SUPERFAMILY database [16], protein domain
assignments for UniProt proteins are monthly updated. It
is done automatically using the HMMER3 package [54]
and expert-curated hidden Markov models representing
all protein domains of known structure [14]. Among
GO-annotated proteins in UniProt, two thirds (over
100,000) were assigned to 1,660 distinct domains at
SCOP superfamily (SF) level and 3,246 distinct domains
at SCOP family (FA) level. A vast number of analyzable
UniProt protein space (i.e., over 100,000 proteins with
GO annotations and domain assignments) secures the
adequate power of statistical inference carried out in this
study.
The definition of supra-domains and being available from
the SUPERFAMILY database
In multidomain proteins, a certain domain tends to co-
occur/co-evolve with other domains. Considering such
promiscuous nature [55] and following on from our pre-
vious descriptions [19], we defined combinations of two
or more successive domains as ‘supra-domains’ if such
combinations were found in more than one distinct
domain architecture. The domain architecture is a modu-
lar view of a protein sequence; in the SUPERFAMILY
database, it is represented as the sequential order of
SCOP domains (at the superfamily level) or gaps (esti-
mated to be one or more unknown domains). The
SUPERFAMILY database contains a total of 14,531 fully-
annotated supra-domains (i.e. containing no unknown
domains) that are present in analyzable UniProt protein
space.
Statistical inference for GO annotations of individual
domains and supra-domains
The brief summary is illustrated in Figure 1. Along with
it, we go through each step in greater detail in the rest of
this section.
Two data sources
We took UniProt proteins with experimentally or manu-
ally curated GO annotations and high-coverage domain/
supra-domain assignments as two training inputs. The
correspondence matrix between domains/supra-domains
and GO terms are tabulated with each entry as observed
number of Uniprot proteins which contain that domain/
supra-domain (given in column) and can be annotated by
that GO term (given in row).
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Two statistical inferences
We used the hypergeometric distribution as a null-
hypothesis and performed statistical test (an equivalent
to Fisher’s exact test) to infer the possible associations
between a GO term and a domain/supra-domain. Terms
in GO are not isolated; rather they are organized as a
directed acyclic graph (DAG) by viewing individual terms
as a node and its relations to parental terms (allowing for
multiple parents) as directed edges. Moreover, GO fol-
lows ‘true-path rule’, that is, a protein/domain annotated
to a term should also be annotated by its all parent
terms. To respect DAG structure and true-path rule, we
conducted two types of statistical inferences. First, we
calculated an overall p-value (and the corresponding
overall hypergeometric score, that is, standard score or z-
score, which is calculated by the observed minus the
expected and then divided by standard deviation under
hypergeometric distribution) using all analyzable UniProt
proteins (i.e., those annotated to the root of GO term
after applying the true-path rule) as the background. We
also calculated a relative p-value (and the corresponding
relative hypergeometric score) using the background of
only those UniProt proteins annotated to all direct paren-
tal GO terms.
Significance and strength of associations
We first took the larger one of the overall and relative
p-values from (2) to indicate the likelihood of associations
between that GO term and that domain/supra-domain.
To account for the multiple hypothesis testing, the Benja-
mini-Hochberg derived FDR [23] rather than the p-value
was used to determine the statistical significance of asso-
ciations between domains/supra-domains and GO terms.
A stringent threshold of FDR (< 10-3) was accepted to sta-
tistically infer GO annotations of individual domains and
supra-domains. In addition to FDR as significant measure,
we also took the smaller of the overall and relative hyper-
geometric scores from (2) to indicate the strength of asso-
ciations, denoted as h-score.
Direct and inherited annotations
According to the true-path rule, the inferred GO terms for
a domain/supra-domain were propagated to all ancestor
terms, along with the FDR and h-score (that is, the mini-
mum FDR and the maximum h-score among all descen-
dants if an ancestor term has multiple descendant terms
annotating that domain/supra-domain). The inferred ori-
ginally were called as direct annotations, the propagated as
inherited annotations; both of them constituted a GO
annotation profile in DAG. Notably, each annotation was
associated with the FDR (indicative of statistical signifi-
cant, and being less than < 10-3) and the h-score (indica-
tive of strength, and the higher the stronger association).
The latter was used for the evaluation of protein function
prediction.
Function prediction of target sequences from the CAFA
experiment
The CAFA experiment [20] provided nearly 47,000 protein
sequences for function prediction, including 7 eukaryotic
sets and 11 prokaryotic sets. These targets were not anno-
tated using ‘EXP’, ‘TAS’ or ‘IC’ evidence codes when avail-
able on the submission deadline (15th, September 2010).
The added-in annotations under these evidence codes
thereafter (till the evaluation time on 19th, November
2011) were served as gold positive standards for evaluating
the function prediction. Both of the prediction and evalua-
tion were restricted to MF and BP ontologies. Since the
prokaryotic sets were exploratory only (insufficient for
evaluation), eukaryotic sets were mainly focused on for the
prediction and evaluation.
For the prediction part (i.e., ‘dcGO Predictor’ [34]), we
first generated domain architectures for the targets and
their derived domains and supra-domains. Then, the
domain-centric GO inferred above was used for function
prediction. If a target contained a domain/supra-domain,
then all GO terms associated to that domain/supra-
domain were transferred to the target (together with
h-scores). When a target-to-term transfer was supported
by one or more residential domains/supra-domains, we
calculated a predictive score (p-score) by additively sum-
ming up h-scores and being scaled to the range of 0-1 (see
Eq. 1). The higher value of the p-score indicates the more
evident the prediction is. Each target (if predictable) was
accompanied by a list of GO terms along with the corre-
sponding predictive scores. The intuition behind this sim-
ple calculation is to rank the predictive p-scores for
precision-recall analysis below.
p− score = (SUM−MIN)/(MAX −MIN), (1)
where SUM is the sum of all h-scores to support a GO
term transferred to the target, MIN and MAX are respec-
tively the minimum and maximum of SUM over a whole
list of predicted GO terms for the target.
For the evaluation part, we first obtained a total of about
246,000 annotations newly added until 19th, November
2011. Based on these gold standards, then we estimated
precision (PR) and recall (RC) for each sequence target
under a given p-score (say t) using Eq. 2 and Eq. 3. All
these calculations were done separately for GO terms in
BP and GO terms in MF. From individual target-specific
PR vs. RC values, the precision (and recall) of each of
eukaryotic sets (and the whole sets) was further calculated
as an average over all targets contained in each set (and
the whole sets).
PR = TP/(TP + FP), (2)
RC = TP/(TP + FN), (3)
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where TP is true positives - calculated as the number of
the predicted GO terms (with p-score larger than t) over-
lapped with gold standards, FP for false positives - the
number of the predicted GO terms that are not in gold
standards, FN for false negatives - the number of gold
standards that are not in the predicted GO terms.
Deriving meta-GO terms of different specificities for
domain-based GO enrichment analysis
We used information content (IC) of a GO term to mea-
sure its specificity in meaning of individual domain and
supra-domain annotations (directed and inherited). For a
given GO term, we defined IC as negative 10-based log-
transformed frequency of domains/supra-domains anno-
tated to that term. The reason behind using IC rather than
the GO tree-like structure is that the GO was originally
designed for annotating proteins, and some parts of GO
structure might be irrelevant to annotate domains/supra-
domains. Similar to our previous report [16], a search pro-
cedure was applied to iteratively walk every possible path
in DAG for partitioning GO under a seed IC. Each parti-
tion was reflective of certain same specificity and con-
tained GO terms located in distinct paths. Four levels of
increasing granularity were defined, that is, being highly
general, general, specific, and highly specific. Based on
these meta-GO terms and their domain-centric annota-
tions, we performed enrichment analysis of domainome
assigned to sequenced eukaryotic genomes (stored in the
SUPERFAMILY database). Enrichment analysis was based
on the hypergeometric distribution, followed by FDR-
based assessment of the statistical significance of GO
enrichments [23]. Like ‘dcGO Predictor’, the ‘dcGO
Enrichment’ [51] is also available to identify functions and
other higher-order knowledge enriched within a list of
protein domains that are submitted by the user.
Data Availability
In additional to two SCOP-orientated and GO-orientated
options for the navigations (the most-left ‘BROWSE’), we
also provided flat files and MySQL tables for the download
on the dcGO website [56].
Additional material
Additional file 1: CAFA function prediction using SCOP individual
domains and supra-domains plus InterPro domains. (A) Precision-
recall curves based on GO annotations of both domains and supra-
domains. The left panel is for the Molecular Function (MF), and the right
panel for Biological Process (BP). (B) The same as in (A) but using
additional InterPro domains (excluding SCOP superfamily domains, SF).
Additional file 2: Performance comparisons between the currently
revised version of ‘dcGO Predictor’ and the old version. The revised
version uses h-scores to calculate p-score while the old version (originally
involved in CAFA before 15th, September 2010) uses the FDR to
calculate p-scores.
Additional file 3: Enriched GO terms for domain repertoire present
at a rapidly evolving metazoan, Oikopleura dioica.
Additional file 4: Enriched GO terms for domain repertoire present
at each of three genomes of animal-fungal boundary.
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